CN106889404A - Lactobacillus-fermented barley beverage and preparation method thereof - Google Patents
Lactobacillus-fermented barley beverage and preparation method thereof Download PDFInfo
- Publication number
- CN106889404A CN106889404A CN201710019361.4A CN201710019361A CN106889404A CN 106889404 A CN106889404 A CN 106889404A CN 201710019361 A CN201710019361 A CN 201710019361A CN 106889404 A CN106889404 A CN 106889404A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus
- fermented
- fructus hordei
- beverage
- hordei vulgaris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007340 Hordeum vulgare Nutrition 0.000 title claims abstract description 44
- 235000013361 beverage Nutrition 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 240000005979 Hordeum vulgare Species 0.000 title 1
- 241000209219 Hordeum Species 0.000 claims abstract description 43
- 229940069780 barley extract Drugs 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 9
- 210000003205 muscle Anatomy 0.000 claims abstract description 9
- 239000000284 extract Substances 0.000 claims description 18
- 238000000855 fermentation Methods 0.000 claims description 13
- 230000004151 fermentation Effects 0.000 claims description 13
- 235000000346 sugar Nutrition 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 5
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000005057 refrigeration Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 235000021552 granulated sugar Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- 229920001202 Inulin Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 2
- 229940029339 inulin Drugs 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 claims 2
- 230000001186 cumulative effect Effects 0.000 claims 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical group C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims 1
- 238000005352 clarification Methods 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N keto-D-fructose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 238000012859 sterile filling Methods 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 98
- 241000894006 Bacteria Species 0.000 abstract description 49
- 239000004310 lactic acid Substances 0.000 abstract description 49
- 235000014655 lactic acid Nutrition 0.000 abstract description 49
- 208000008589 Obesity Diseases 0.000 abstract description 8
- 235000020824 obesity Nutrition 0.000 abstract description 8
- 230000001965 increasing effect Effects 0.000 abstract description 7
- 235000013339 cereals Nutrition 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 210000000593 adipose tissue white Anatomy 0.000 abstract description 2
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 8
- 102000015779 HDL Lipoproteins Human genes 0.000 description 6
- 108010010234 HDL Lipoproteins Proteins 0.000 description 6
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 6
- 206010022489 Insulin Resistance Diseases 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000009200 high fat diet Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 238000012371 Aseptic Filling Methods 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000009455 aseptic packaging Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000031648 Body Weight Changes Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000004579 body weight change Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229930182843 D-Lactic acid Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/84—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter using microorganisms or biological material, e.g. enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明涉及乳酸菌发酵大麦饮料及其制备方法,属于非酒精饮料的制备技术领域。乳酸菌发酵大麦饮料由乳酸菌发酵大麦提取液和辅料组成,其中乳酸菌发酵大麦提取液:辅料(质量比)为100:5~15。本发明所制成的乳酸菌发酵大麦饮料具有增加人体肌肉量,提高机体运动能力,促进白色脂肪棕色化以及抑制肥胖的作用。其制作方法简单,成本低,产品风味独特,营养价值高,是一种健康型的谷物饮料。
The invention relates to lactic acid bacteria fermented barley beverage and a preparation method thereof, belonging to the technical field of non-alcoholic beverage preparation. The lactic acid bacteria fermented barley beverage is composed of lactic acid bacteria fermented barley extract and auxiliary materials, wherein the lactic acid bacteria fermented barley extract: auxiliary material (mass ratio) is 100:5~15. The lactic acid bacterium fermented barley drink prepared by the invention has the effects of increasing the muscle mass of the human body, improving the exercise ability of the body, promoting the browning of white fat and suppressing obesity. The preparation method is simple, the cost is low, the product has unique flavor and high nutritional value, and is a healthy grain drink.
Description
技术领域technical field
本发明涉及一种乳酸发酵大麦饮料及其制备方法,属于非酒精饮料的制备技术领域。The invention relates to a lactic acid fermented barley beverage and a preparation method thereof, belonging to the technical field of non-alcoholic beverage preparation.
背景技术Background technique
近年来全谷物的健康功能已受到各国的广泛关注。我国大麦的种植横跨东西,纵贯南北,区域广泛,资源丰富。但目前大麦主要用于饲料和啤酒行业,对食用大麦深加工的利用率极低。大麦含有丰富的β-葡聚糖、蛋白质、黄酮和多酚类化合物等多种活性成分,具有调节血糖、降血脂、降低胆固醇,改善肥胖等功能。随着科学技术的发展,生物加工(发酵)技术与传统谷物食品的结合已显露出其前所未有的重要影响,已有研究发现传统谷物食品经发酵后其品质明显改善,功能活性显著提高,应用范围也得到了拓宽,具有显著的开发潜力和应用前景。In recent years, the health function of whole grains has been widely concerned by various countries. my country's barley planting spans from east to west, from north to south, in a wide area and rich in resources. But at present, barley is mainly used in feed and beer industries, and the utilization rate of edible barley for deep processing is extremely low. Barley is rich in β-glucan, protein, flavonoids and polyphenolic compounds and other active ingredients, which have the functions of regulating blood sugar, lowering blood fat, lowering cholesterol, and improving obesity. With the development of science and technology, the combination of bioprocessing (fermentation) technology and traditional grain food has shown its unprecedented important influence. It has been found that the quality of traditional grain food after fermentation is significantly improved, and the functional activity is significantly improved. The scope of application It has also been broadened and has significant development potential and application prospects.
中国专利CN103549613A公开了大麦饮品及其制备方法,该方法提高了大麦的有效使用率,相比较浓缩液,其营养成分以及口感均会更佳且能有效保护好大麦原有的色香味,使得制得的饮料的口感更加纯正。日本专利WO2007034958公开了一种脱壳大麦的乙醇提取物、碱提取物和发酵产物的制备方法,其活性成分具有抑制血管生成的作用;我国发明专利CN103271303提供了用乳酸菌发酵已春化处理预发芽的大麦作为功能食品原料的方法,此原料表现出更高的抗氧化性和超氧化物阴离子自由基清除活性,同时降低糖尿病小鼠的血糖水平和肥胖程度;中国专利CN201310264094.9公开了乳酸菌发酵大麦提取物的制备方法及其抗肿瘤作用。乳酸菌发酵大麦提取物能够有效的抑制肿瘤的生长。中国专利CN201510073680.4公开了乳酸菌发酵大麦提取物及其制备方法与用途,通过乳酸菌发酵大麦,可以实现营养组分的生物转化。乳酸菌发酵大麦提取物可作为抑制肥胖及改善胰岛素抵抗的功能食品或食品原料。我国发明专利CN104721652A提供了一种乳酸菌发酵大麦粉及其制备方法与用途,乳酸菌发酵大麦粉可显著降低肥胖大鼠模型的血糖含量,提高机体糖耐量,同时显著改善脂代谢紊乱,降低血清胆固醇和甘油三脂含量,增加高密度脂蛋白含量,可用于预防和干预高血糖、高血脂等慢性病的产生,改善高胰岛素血症以及肥胖诱发的胰岛素抵抗。Chinese patent CN103549613A discloses barley drink and its preparation method. This method improves the effective utilization rate of barley. Compared with concentrated liquid, its nutritional content and taste will be better and can effectively protect the original color, aroma and taste of barley, making the preparation The mouthfeel of the obtained drink is purer. Japanese patent WO2007034958 discloses a preparation method of ethanol extract, alkali extract and fermentation product of husked barley, the active ingredient of which has the effect of inhibiting angiogenesis; Chinese invention patent CN103271303 provides pre-germination with lactic acid bacteria fermentation and vernalization treatment The method of using barley as a functional food raw material, this raw material exhibits higher antioxidant and superoxide anion radical scavenging activities, and at the same time reduces blood sugar levels and obesity in diabetic mice; Chinese patent CN201310264094.9 discloses lactic acid bacteria fermentation Preparation method of barley extract and its antitumor effect. Lactic acid bacteria fermented barley extract can effectively inhibit the growth of tumors. Chinese patent CN201510073680.4 discloses an extract of barley fermented by lactic acid bacteria and its preparation method and application, and the biotransformation of nutritional components can be realized by fermenting barley with lactic acid bacteria. Lactic acid bacteria fermented barley extract can be used as functional food or food raw material to suppress obesity and improve insulin resistance. my country's invention patent CN104721652A provides a lactic acid bacteria fermented barley flour and its preparation method and application. The lactic acid bacteria fermented barley flour can significantly reduce the blood sugar content of obese rat models, improve the body's glucose tolerance, and at the same time significantly improve lipid metabolism disorders, reduce serum cholesterol and Triglyceride content, increase high-density lipoprotein content, can be used to prevent and intervene in the occurrence of chronic diseases such as hyperglycemia and hyperlipidemia, and improve hyperinsulinemia and insulin resistance induced by obesity.
大麦饮料可以满足当前人们快节奏生活的营养补给需求,同时经过发酵的大麦提取物具有抗氧化,抗肿瘤以及抗肥胖等功能。因此,以大麦为原料开发的乳酸菌发酵饮料必将具有很大的市场需求。Barley beverages can meet the nutritional supplement needs of people's fast-paced life. At the same time, the fermented barley extract has anti-oxidation, anti-tumor and anti-obesity functions. Therefore, the lactic acid bacteria fermented beverage developed with barley as a raw material will have a great market demand.
发明内容Contents of the invention
本发明的目的是以大麦为原料,利用乳酸菌发酵,提供一种乳酸菌发酵大麦饮料及其制备方法。The object of the invention is to provide a lactic acid bacteria fermented barley beverage and a preparation method thereof by taking barley as a raw material and utilizing lactic acid bacteria for fermentation.
本发明提供的乳酸菌发酵大麦饮料由乳酸菌发酵大麦提取液和辅料组成,其中乳酸菌发酵大麦提取液和辅料的质量比为100:5~15。The lactic acid bacteria fermented barley beverage provided by the invention is composed of lactic acid bacteria fermented barley extract and auxiliary materials, wherein the mass ratio of the lactic acid bacteria fermented barley extract to the auxiliary materials is 100:5-15.
其中所述的辅料为糖、稳定剂等。Wherein said adjuvant is sugar, stabilizer etc.
所述糖为白砂糖、麦芽糖醇、三氯蔗糖、阿斯巴甜、果糖、糖浆、菊粉和低聚糖的一种或多种组合,其添加量占成品总体积的9~14%(m/v,g/L)。The sugar is one or more combinations of white granulated sugar, maltitol, sucralose, aspartame, fructose, syrup, inulin and oligosaccharides, and its added amount accounts for 9-14% of the total volume of the finished product ( m/v, g/L).
所述稳定剂为黄原胶、海藻酸钠、羧甲基纤维素钠、阿拉伯胶、果胶的一种或多种组合,其添加量占成品总体积的1~2%(m/v,g/L)。The stabilizer is one or more combinations of xanthan gum, sodium alginate, sodium carboxymethylcellulose, gum arabic, and pectin, and its addition accounts for 1 to 2% of the total volume of the finished product (m/v, g/L).
本发明所述的乳酸菌发酵大麦饮料的制备方法,按照下述步骤进行:The preparation method of lactic acid bacteria fermented barley beverage of the present invention, carries out according to the following steps:
(1)乳酸菌发酵大麦提取液的制备:发酵初始pH=5-6、固液比为1:7-1:13、每克大麦粉添加7×107cfu-9×107cfu的植物乳杆菌Lactobacillus plantarum、发酵温度为30-35℃、发酵时间为18-30h;以此工艺进行发酵后,8000-12000rpm/min离心得到的上清液为乳酸菌发酵大麦提取液;(1) Preparation of lactic acid bacteria fermented barley extract: initial fermentation pH=5-6, solid-liquid ratio 1:7-1:13, adding 7×10 7 cfu-9×10 7 cfu vegetable milk per gram of barley flour Bacillus Lactobacillus plantarum, the fermentation temperature is 30-35°C, and the fermentation time is 18-30h; after fermentation by this process, the supernatant obtained by centrifugation at 8000-12000rpm/min is the extract of barley fermented by lactic acid bacteria;
(2)乳酸菌发酵大麦提取液的抗氧化处理:每100mL加入1-2gβ-环糊精,40℃水浴10-15min,期间不断搅拌至发酵液澄清;(2) Antioxidant treatment of lactic acid bacteria fermented barley extract: add 1-2g β-cyclodextrin per 100mL, bathe in water at 40°C for 10-15min, and keep stirring until the fermentation broth is clarified;
(3)调配:根据需要添加灭菌的糖、稳定剂等辅料到经过抗氧化处理的乳酸菌发酵大麦提取液中,搅拌混合均匀。(3) Blending: add sterilized sugar, stabilizers and other auxiliary materials to the antioxidant-treated lactic acid bacteria fermented barley extract as required, and stir to mix evenly.
(4)灭菌:在温度为115~121℃条件下灭菌处理15~25min。(4) Sterilization: Sterilize at a temperature of 115-121°C for 15-25 minutes.
(5)无菌灌装:调配好的饮料在无菌条件下装入无菌包装容器中。(5) Aseptic filling: the prepared beverage is filled into aseptic packaging containers under aseptic conditions.
(6)冷藏:在0~5℃条件下冷藏。(6) Refrigeration: Refrigerate at 0-5°C.
所述的乳酸菌发酵大麦饮料具有增加人体肌肉量,提高机体运动能力的作用。The lactic acid bacteria fermented barley beverage has the effects of increasing the muscle mass of the human body and improving the exercise capacity of the body.
所述的乳酸菌发酵大麦饮料具有使白色脂肪棕色化,从而抑制肥胖的效果。The lactic acid bacterium fermented barley beverage has the effect of browning white fat, thereby suppressing obesity.
所述的乳酸菌发酵大麦饮料可作为一种运动型饮料。The lactic acid bacteria fermented barley drink can be used as a sports drink.
所述的乳酸菌发酵大麦饮料可作为老年肌肉量补充型饮料。The lactic acid bacterium fermented barley beverage can be used as a type of beverage for replenishing muscle mass of the elderly.
本发明有益效果:Beneficial effects of the present invention:
(1)本发明所述的乳酸菌发酵大麦饮料制备方法简单,成本低,产品风味独特,营养价值高,适于产业化应用。(1) The preparation method of the lactic acid bacteria fermented barley beverage of the present invention is simple, low in cost, unique in flavor and high in nutritional value, and is suitable for industrial application.
(2)本发明所述的乳酸菌发酵大麦饮料具有提高肌肉量的功能,故特别适用于作为运动饮料和老年肌肉量补充型饮料。(2) The lactic acid bacteria fermented barley drink of the present invention has the function of increasing muscle mass, so it is especially suitable as a sports drink and a muscle mass replenishing drink for the elderly.
附图说明Description of drawings
图1加糖量对乳酸菌发酵大麦饮料感官评定值的影响Figure 1 Effect of sugar addition on sensory evaluation value of lactic acid bacteria fermented barley beverage
图2为本发明所述三组SD大鼠体重变化情况;注:NC:正常组;HFD:高脂饮食组;LFBE:乳酸菌发酵大麦饮料组。Figure 2 shows the body weight changes of SD rats in three groups of the present invention; Note: NC: normal group; HFD: high-fat diet group; LFBE: lactic acid bacteria fermented barley beverage group.
图3为本发明所述三组SD大鼠体脂肪含量变化情况;注:NC:正常组;HFD:高脂饮食组;LFBE:乳酸菌发酵大麦饮料组。Fig. 3 is the change of body fat content of three groups of SD rats according to the present invention; Note: NC: normal group; HFD: high-fat diet group; LFBE: lactic acid bacteria fermented barley beverage group.
具体实施方式detailed description
实施例一Embodiment one
1.乳酸菌发酵大麦提取液的制备:选取新鲜脱壳大麦,磨粉,过100目筛,向大麦粉中加入11倍质量的蒸馏水,按1×108接种活化至对数后期的植物乳杆菌Lactobacillusplantarum dy-1,(该菌株已经获批中国发明专利,专利号为:ZL201310261606.6,专利名称为:一种发酵谷物的乳酸菌及其用途),搅拌5min,30℃下发酵24h,得到发酵物,将发酵物在室温下于10000rpm/min下离心20min,收集上清液,即得乳酸菌发酵大麦提取液。1. Preparation of lactic acid bacteria fermented barley extract: select fresh shelled barley, grind it into powder, pass through a 100-mesh sieve, add 11 times the quality of distilled water to the barley flour, and inoculate Lactobacillus plantarum activated to late logarithmic stage by 1 ×108 Lactobacillusplantarum dy-1, (the strain has been approved as a Chinese invention patent, the patent number is: ZL201310261606.6, and the patent name is: a lactic acid bacterium for fermenting grains and its use), stirred for 5 minutes, fermented at 30°C for 24 hours to obtain a fermented product , centrifuge the fermented product at room temperature at 10000 rpm/min for 20 min, collect the supernatant, and obtain the lactic acid bacteria fermented barley extract.
2.调配:将白砂糖以14%比例,黄原胶以1%的比例添加到15L乳酸菌发酵大麦提取液中。2. Blending: add white granulated sugar at a ratio of 14% and xanthan gum at a ratio of 1% to 15L of lactic acid bacteria fermented barley extract.
3.灭菌:在温度为115℃条件下灭菌处理25min。3. Sterilization: Sterilize at a temperature of 115°C for 25 minutes.
4.无菌灌装:调配好的饮料在无菌条件下装入无菌包装容器中。4. Aseptic filling: the prepared beverage is filled into aseptic packaging containers under aseptic conditions.
5.冷藏:在4℃条件下冷藏。5. Refrigeration: Refrigerate at 4°C.
表1 感官评定参考标准Table 1 Sensory evaluation reference standard
由图1可知,感官评定值随白砂糖加糖量的增加先上升后下降,在白砂糖的添加量在14%时感官评定值为82,达到最大值。白砂糖的添加量太少,饮料的口感过酸,难以被人接受;添加量太多,饮料口感过甜,不仅不容易被人接受,摄入的糖量也过高,不利于健康。It can be seen from Figure 1 that the sensory evaluation value increases first and then decreases with the increase of the amount of white sugar added, and the sensory evaluation value reaches the maximum value of 82 when the added amount of white sugar is 14%. If the amount of white sugar added is too small, the taste of the drink will be too sour, which is difficult to be accepted by people;
实施例二(可供肥胖及糖尿病人食用)Embodiment two (can be eaten by obese and diabetic people)
1.乳酸菌发酵大麦饮料的制备1. Preparation of lactic acid bacteria fermented barley beverage
(1)乳酸菌发酵大麦提取液的制备:选取新鲜脱壳大麦,磨粉,过100目筛,向大麦粉中加入7倍质量的蒸馏水,按1×108接种活化至对数后期的植物乳杆菌Lactobacillusplantarum dy-1,(该菌株已经获批中国发明专利,专利号为:ZL201310261606.6,专利名称为:一种发酵谷物的乳酸菌及其用途),搅拌5min,30℃下发酵24h,得到发酵物,将发酵物在室温下于10000rpm/min下离心20min,收集上清液,即得乳酸菌发酵大麦提取液。(1) Preparation of lactic acid bacteria fermented barley extract: select fresh husked barley, grind it into powder, pass through a 100-mesh sieve, add 7 times the mass of distilled water to the barley flour, and inoculate 1 ×108 vegetable milk activated to the late logarithmic stage Bacillus Lactobacillusplantarum dy-1, (the strain has been approved as a Chinese invention patent, the patent number is: ZL201310261606.6, and the patent name is: a lactic acid bacterium for fermenting grains and its use), stirred for 5 minutes, and fermented at 30°C for 24 hours to obtain fermented Centrifuge the fermented product at room temperature at 10,000 rpm/min for 20 min, collect the supernatant, and obtain the lactic acid bacteria fermented barley extract.
(2)调配:将三氯蔗糖以4%比例,黄原胶以1%的比例添加到20L乳酸菌发酵大麦提取液中。(2) Blending: add sucralose at a ratio of 4% and xanthan gum at a ratio of 1% to 20L of lactic acid bacteria fermented barley extract.
(3)灭菌:在温度为115℃条件下灭菌处理25min。(3) Sterilization: Sterilize at a temperature of 115° C. for 25 minutes.
(4)无菌灌装:调配好的饮料在无菌条件下装入无菌包装容器中。(4) Aseptic filling: the prepared beverage is filled into aseptic packaging containers under aseptic conditions.
(5)冷藏:在4℃条件下冷藏。(5) Refrigeration: Refrigerate at 4°C.
2.实验动物及饲养条件2. Experimental animals and feeding conditions
清洁级健康SD大鼠48只,5~6周龄,180~200g左右,雄性,购于江苏大学实验动物中心,试验过程符合江苏省实验动物管理委员会和国家实验动物福利保护的规定,大鼠饲养于江苏大学实验动物中心动物房:室温(25±2)℃,相对湿度(55±5)%,12h/12h光照,自由获取食物和饮水。48 clean-grade healthy SD rats, 5-6 weeks old, about 180-200g, male, were purchased from the Experimental Animal Center of Jiangsu University. Raised in the animal room of the Experimental Animal Center of Jiangsu University: room temperature (25±2)°C, relative humidity (55±5)%, 12h/12h light, free access to food and drinking water.
3.实验方法3. Experimental method
在SD大鼠适应环境1周后,将36只SD雄性大鼠按平均体重随机分成3组:第一组为对照组,饲喂基础饲料,同时灌胃生理盐水;第二组为高脂饮食组(HFD),饲喂高脂饲料(73%基础饲料、12%猪油、10%白砂糖以及5%蛋黄粉),同时灌胃生理盐水;第三组为乳酸菌发酵大麦饮料(LFBE)组,饲喂高脂饲料(73%基础饲料、12%猪油、10%白砂糖以及5%蛋黄粉),同时灌胃1g/kg/d的乳酸菌发酵大麦饮料组。After the SD rats adapted to the environment for 1 week, 36 SD male rats were randomly divided into 3 groups according to the average body weight: the first group was the control group, which was fed with basal feed and intragastrically administered normal saline; the second group was fed with a high-fat diet group (HFD), fed high-fat feed (73% basic feed, 12% lard, 10% white sugar and 5% egg yolk powder), and administered normal saline; the third group was the lactic acid bacteria fermented barley beverage (LFBE) group , fed high-fat feed (73% basic feed, 12% lard, 10% white sugar and 5% egg yolk powder), and fed 1g/kg/d lactic acid bacteria fermented barley beverage group simultaneously.
各组试验大鼠均连续灌胃14周,每天一次,记录每组大鼠周体重变化。每隔7周测定口服糖耐量;末次灌胃后禁食8h,次日,采用水合氯醛麻痹,腹主动脉取血,3500rpm离心10min分离血清,-20℃保存。解剖大鼠取附睾脂肪和腹部脂肪,用生理盐水漂净、滤干后称重。The test rats in each group were continuously orally administered for 14 weeks, once a day, and the weekly body weight changes of the rats in each group were recorded. Oral glucose tolerance was measured every 7 weeks; fasted for 8 hours after the last gavage, paralyzed with chloral hydrate the next day, blood was collected from the abdominal aorta, centrifuged at 3500rpm for 10min to separate the serum, and stored at -20°C. The rats were dissected to take epididymis fat and abdominal fat, which were rinsed with normal saline, filtered and dried, and then weighed.
血脂水平的测定:大鼠血清中甘油三酯(TG)、总胆固醇(CHOL)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)的含量采用全自动生化分析仪测定。Determination of blood lipid levels: the contents of triglyceride (TG), total cholesterol (CHOL), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) in rat serum were determined by an automatic biochemical analyzer.
4.实验结果4. Experimental results
(1)三组SD大鼠血脂水平变化情况(1) Changes of blood lipid levels in three groups of SD rats
机体血脂水平异常改变,可导致体内脂质异常蓄积,诱发机体产生高脂血症,严重者可引起动脉粥样硬化、冠心病等的发生;有报道表明,肥胖大鼠出现胰岛素抵抗的同时,还伴随脂代谢紊乱。如表2所示,与正常对照组相比,HFD组大鼠血清TG(甘油三脂)和TC(总胆固醇)含量显著升高,大鼠血清中HDL(高密度脂蛋白)含量则显著降低,大鼠血清中LDL(低密度脂蛋白)含量并无显著性的差异,这显然与肥胖伴随的高脂血症有关。灌胃14周乳酸菌发酵大麦提取物饮料后,与HFD组相比,LFBE组大鼠血清中TG和TC含量均显著的降低,大鼠血清中HDL含量显著升高,LFBE组大鼠血清LDL含量与HFD组相比没有显著差异(p>0.05)。Abnormal changes in blood lipid levels in the body can lead to abnormal accumulation of lipids in the body and induce hyperlipidemia in the body. In severe cases, it can cause atherosclerosis, coronary heart disease, etc.; reports have shown that insulin resistance occurs in obese rats. Also accompanied by lipid metabolism disorders. As shown in Table 2, compared with the normal control group, the serum TG (triglyceride) and TC (total cholesterol) contents of the rats in the HFD group were significantly increased, and the HDL (high-density lipoprotein) contents in the rat serum were significantly decreased , There was no significant difference in LDL (low-density lipoprotein) content in rat serum, which was obviously related to the hyperlipidemia associated with obesity. After 14 weeks of intragastric administration of lactic acid bacteria fermented barley extract drink, compared with the HFD group, the TG and TC contents in the serum of the rats in the LFBE group were significantly reduced, the HDL contents in the rat serum were significantly increased, and the serum LDL contents in the rats in the LFBE group were significantly lower than those in the HFD group. Compared with the HFD group, there was no significant difference (p>0.05).
表2 三组SD大鼠血脂水平变化情况Table 2 Changes of blood lipid levels in three groups of SD rats
注:具有不同的字母标记则认为具有显著差异(p<0.05)。Note: Different letter marks are considered to have significant differences (p<0.05).
(2)三组SD大鼠体重和体脂肪含量变化情况(2) Changes in body weight and body fat content of three groups of SD rats
由图2中数据可以看出,14周的干预期间,正常组大鼠体重明显低于模型对照组。灌胃14周LFBE组的大鼠也明显低于模型对照组,结果表明,乳酸菌发酵大麦提取物饮料可以显著地减少大鼠体重增加。LFBE对大鼠体脂肪含量的影响结果见图3。由图可知,与正常大鼠相比,HFD组大鼠的体脂肪含量显著增加,占总体重的5.05%。LFBE灌胃14周后,与HFD组相比,高脂饮食的大鼠体脂肪含量显著下降,为3.21%。It can be seen from the data in Figure 2 that during the 14-week intervention period, the body weight of rats in the normal group was significantly lower than that of the model control group. The rats in the LFBE group after intragastric administration for 14 weeks were also significantly lower than the model control group. The results showed that the lactic acid bacteria fermented barley extract drink could significantly reduce the weight gain of rats. The effect of LFBE on the body fat content of rats is shown in Figure 3. It can be seen from the figure that compared with the normal rats, the body fat content of the rats in the HFD group increased significantly, accounting for 5.05% of the total body weight. After LFBE gavage for 14 weeks, compared with the HFD group, the body fat content of the rats on the high-fat diet decreased significantly, which was 3.21%.
正常情况下,动物摄取一定的饲料,用于维持体温、促进生长,当过量摄取高脂饲料时,体内能量代谢失衡,过多的能量转变成脂肪和蛋白,造成机体肥胖,在病态生理状态或不良生活方式下,导致胰岛素抵抗或2型糖尿病的发生。而灌胃乳酸菌发酵大麦提取物饮料组的大鼠运动能力明显增强,肌肉中的蛋白含量明显增加。Under normal circumstances, animals take a certain amount of feed to maintain body temperature and promote growth. When excessive intake of high-fat feed occurs, the energy metabolism in the body becomes unbalanced, and the excess energy is converted into fat and protein, resulting in obesity. Unhealthy lifestyle can lead to insulin resistance or type 2 diabetes. However, the exercise ability of the rats in the lactic acid bacteria fermented barley extract beverage group was significantly enhanced, and the protein content in the muscle was significantly increased.
综上所述,与HFD组相比,乳酸菌发酵大麦饮料能显著降低饮食诱导的肥胖大鼠的体重及体脂肪含量,同时还能降低血清TG和TC含量、增强大鼠运动能力。因此,乳酸菌发酵大麦提取物饮料改善胰岛素抵抗作用机制与抑制TG和TC的合成、增强肌肉活动能力有关。In summary, compared with the HFD group, lactic acid bacteria fermented barley beverage can significantly reduce the body weight and body fat content of diet-induced obese rats, and can also reduce serum TG and TC levels, and enhance the exercise capacity of rats. Therefore, the mechanism of lactic acid bacteria fermented barley extract beverage to improve insulin resistance is related to inhibiting the synthesis of TG and TC and enhancing muscle activity.
所述实施例为本发明的优选的实施方式,但本发明并不限于上述实施方式,在不背离本发明的实质内容的情况下,本领域技术人员能够做出的任何显而易见的改进、替换或变型均属于本发明的保护范围。The described embodiment is a preferred implementation of the present invention, but the present invention is not limited to the above-mentioned implementation, without departing from the essence of the present invention, any obvious improvement, replacement or modification that those skilled in the art can make Modifications all belong to the protection scope of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710019361.4A CN106889404A (en) | 2017-01-11 | 2017-01-11 | Lactobacillus-fermented barley beverage and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710019361.4A CN106889404A (en) | 2017-01-11 | 2017-01-11 | Lactobacillus-fermented barley beverage and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106889404A true CN106889404A (en) | 2017-06-27 |
Family
ID=59197895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710019361.4A Pending CN106889404A (en) | 2017-01-11 | 2017-01-11 | Lactobacillus-fermented barley beverage and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106889404A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109349482A (en) * | 2018-10-23 | 2019-02-19 | 江苏大学 | A kind of preparation method of fermented beverage with fried barley as raw material |
| CN111493313A (en) * | 2020-04-21 | 2020-08-07 | 江苏瑞牧生物科技有限公司 | Functional barley composite whole powder based on lactobacillus fermentation and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102018260A (en) * | 2010-12-10 | 2011-04-20 | 江南大学 | Preparation method of wort lactic acid bacteria beverage |
| CN103211267A (en) * | 2013-04-27 | 2013-07-24 | 黑龙江八一农垦大学 | Fermented beverage of full cereal grains |
| CN103445068A (en) * | 2013-06-26 | 2013-12-18 | 江苏大学 | Preparation method of barley extract fermented by lactobacillus and anti-tumor effect of barley extract fermented by lactobacillus |
| CN103468600A (en) * | 2013-06-26 | 2013-12-25 | 江苏大学 | Lactic acid bacterium used for fermenting cereal and applications thereof |
| CN103689741A (en) * | 2013-12-11 | 2014-04-02 | 广东省农业科学院蚕业与农产品加工研究所 | Method of preparing rice bran beverage employing enzymic method in cooperation with lactic acid fermentation |
| CN104544419A (en) * | 2013-10-18 | 2015-04-29 | 刘俊 | Barley fermentation beverage production technology |
| CN104621566A (en) * | 2015-02-11 | 2015-05-20 | 江苏大学 | Lactic acid bacteria fermented barley extract and its preparation method and application |
| CN104721652A (en) * | 2015-02-11 | 2015-06-24 | 江苏大学 | Lactobacillus fermented barley meal as well as preparation method and application thereof |
-
2017
- 2017-01-11 CN CN201710019361.4A patent/CN106889404A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102018260A (en) * | 2010-12-10 | 2011-04-20 | 江南大学 | Preparation method of wort lactic acid bacteria beverage |
| CN103211267A (en) * | 2013-04-27 | 2013-07-24 | 黑龙江八一农垦大学 | Fermented beverage of full cereal grains |
| CN103445068A (en) * | 2013-06-26 | 2013-12-18 | 江苏大学 | Preparation method of barley extract fermented by lactobacillus and anti-tumor effect of barley extract fermented by lactobacillus |
| CN103468600A (en) * | 2013-06-26 | 2013-12-25 | 江苏大学 | Lactic acid bacterium used for fermenting cereal and applications thereof |
| CN104544419A (en) * | 2013-10-18 | 2015-04-29 | 刘俊 | Barley fermentation beverage production technology |
| CN103689741A (en) * | 2013-12-11 | 2014-04-02 | 广东省农业科学院蚕业与农产品加工研究所 | Method of preparing rice bran beverage employing enzymic method in cooperation with lactic acid fermentation |
| CN104621566A (en) * | 2015-02-11 | 2015-05-20 | 江苏大学 | Lactic acid bacteria fermented barley extract and its preparation method and application |
| CN104721652A (en) * | 2015-02-11 | 2015-06-24 | 江苏大学 | Lactobacillus fermented barley meal as well as preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 李明松,等: "β-环糊精提高乳酸菌发酵大麦粉提取物的抗氧化及机构稳定性研究", 《中国食品科学技术学会第十三届年会论文摘要集》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109349482A (en) * | 2018-10-23 | 2019-02-19 | 江苏大学 | A kind of preparation method of fermented beverage with fried barley as raw material |
| CN111493313A (en) * | 2020-04-21 | 2020-08-07 | 江苏瑞牧生物科技有限公司 | Functional barley composite whole powder based on lactobacillus fermentation and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102687750B (en) | Weight losing and meal replacement protein type solid beverage | |
| US7977319B1 (en) | Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins | |
| US20160242450A1 (en) | Functional-gel Compositions and Methods | |
| CN104544432B (en) | Samara oil compound protein solid beverage and method for preparing same | |
| CN117958446B (en) | Composition for reducing weight and body fat, preparation method and application thereof | |
| JP2011505870A (en) | Method for producing functional food product based on egg yolk and product obtained thereby | |
| CN101912090B (en) | Highland barley health care porridge assisting for reducing blood fat and preparation method thereof | |
| JP2013513368A (en) | Nutritional products containing hydrolyzed whole grains | |
| CN106036342A (en) | Dietary supplement solid drink suitable for people with diabetes and preparation method thereof | |
| CN111280280A (en) | Low-sugar weight-reducing coffee and preparation method thereof | |
| JP2022031912A (en) | Oral composition | |
| CN110522034A (en) | A functional food containing Lactobacillus niger fermented product and its application | |
| CN105031042A (en) | Medicinal composition having weight-loss function and application of medicinal composition | |
| CN106889404A (en) | Lactobacillus-fermented barley beverage and preparation method thereof | |
| CN105265960A (en) | Fruit and vegetable drink special for patient suffering from diabetes | |
| CN118633736A (en) | A kind of diglyceride, triglyceride mixed fat powder and its preparation method and application | |
| JP2016047036A (en) | Health food | |
| CN112568444A (en) | Composition for relieving muscle loss and preparation method thereof | |
| KR101883787B1 (en) | Powdery food comprising stachys sieboldii and gaba-enhanced germinated grain and its preparing method | |
| KR20080088231A (en) | Weight control preparation and cup container comprising the same | |
| Cozzolino et al. | Functional food: Product development and health benefits | |
| CN103876204B (en) | A kind of breast milk Walnut Milk and preparation method thereof | |
| KR102439609B1 (en) | Powdered yogurt containing sprouted barley shoots and manufacturing method | |
| JP2007037525A (en) | Health food | |
| JP7650044B2 (en) | Glucose adsorbent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170627 |